Annual Meeting Highlights

2014 American Society of Hematology (ASH) Annual Meeting Conference Highlights in Chronic Myelogenous Leukemia
2014 American Society of Hematology (ASH) Annual Meeting Conference Highlights in Chronic Myelogenous Leukemia
CME, CPE, CNE
Jorge E. Cortes, MD; Stuart L. Goldberg, MD; Michael J. Mauro, MD; Jerald P. Radich, MD
Release Date: December 22, 2014
Expiration Date: December 22, 2015

In this educational activity, clinical experts discuss key abstracts related to CML from the 2014 American Society of Hematology Meeting.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from ARIAD Pharmaceuticals, Inc., Novartis, and Teva Pharmaceuticals.
View Only, CE ExpiredView Only, No Credit
 
ESH-iCMLf 16th International Conference Highlights in Chronic Myelogenous Leukemia
ESH-iCMLf 16th International Conference Highlights in Chronic Myelogenous Leukemia
CME, CPE, CNE
Timothy P. Hughes, MD; Michael J. Mauro, MD; Danilo Perrotti, MD, PhD
Release Date: November 05, 2014
Expiration Date: November 05, 2015

Drs. Timothy Hughes, Michael Mauro, and Danilo Perrotti present meeting highlights in chronic myelogenous leukemia from ESH-iCMLf 16th International Conference on Chronic Myeloid Leukemia-Biology and Therapy.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from ARIAD Pharmaceuticals, Inc., Novartis, and Teva Pharmaceuticals.
View Only, CE ExpiredView Only, No Credit
 
ASH 2013: Highlights in Chronic Myelogenous Leukemia
ASH 2013: Highlights in Chronic Myelogenous Leukemia
CME, CPE, CNE
Neil P. Shah, MD, PhD - Moderator; Jorge Eduardo Cortes, MD; Michael Deininger, MD, PhD; Satu Mustjoki, MD, PhD; Javier Pinilla-Ibarz, MD, PhD; Richard A. Van Etten, MD, PhD
Release Date: December 19, 2013
Expiration Date: December 19, 2014

In this educational activity, clinical experts discuss key findings relative to new and emerging treatments for chronic myelogenous leukemia (CML) from the 2013 ASH Meeting. Each module will focus on the latest data, on what the data means in the clinical setting, and how clinicians may effectively incorporate this information to improve patient care, and ultimately, patient outcomes.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Teva Pharmaceuticals and Novartis.
View Only, CE ExpiredView Only, No Credit
 
ASCO 2013: Highlights in Chronic Myelogenous Leukemia
ASCO 2013: Highlights in Chronic Myelogenous Leukemia
CME, CPE, CNE
Jorge Eduardo Cortes, MD; Stuart L. Goldberg, MD; Michael J. Mauro, MD
Release Date: June 19, 2013
Expiration Date: June 19, 2014

In this educational activity, clinical experts discuss key findings relative to new and emerging treatments for chronic myelogenous leukemia (CML) from the 2013 ASCO meeting. Each module will focus on the latest data, on what the data means in the clinical setting, and how clinicians may effectively incorporate this information to improve patient care, and ultimately, patient outcomes.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Teva Pharmaceuticals and Novartis.
View Only, CE ExpiredView Only, No Credit